The infection fatality rate of COVID-19 inferred from seroprevalence data
John P.A. Ioannidis
doi: https://doi.org/10.1101/2020.05.13.20101253
John P.A. Ioannidis
Departments of Medicine, of Epidemiology and Population Health, of Biomedical Data Science, and of Statistics and Meta-Research Innovation Center at Stanford (METRICS), Stanford University, Stanford, CA, USA

Data Availability
All data are included in the manuscript
Posted July 14, 2020.
The infection fatality rate of COVID-19 inferred from seroprevalence data
John P.A. Ioannidis
medRxiv 2020.05.13.20101253; doi: https://doi.org/10.1101/2020.05.13.20101253
Subject Area
Subject Areas
- Addiction Medicine (179)
- Allergy and Immunology (434)
- Anesthesia (99)
- Cardiovascular Medicine (948)
- Dermatology (110)
- Emergency Medicine (260)
- Epidemiology (8987)
- Gastroenterology (420)
- Genetic and Genomic Medicine (1959)
- Geriatric Medicine (190)
- Health Economics (402)
- Health Informatics (1329)
- Health Policy (660)
- Hematology (212)
- HIV/AIDS (420)
- Medical Education (200)
- Medical Ethics (54)
- Nephrology (222)
- Neurology (1830)
- Nursing (110)
- Nutrition (274)
- Oncology (999)
- Ophthalmology (298)
- Orthopedics (111)
- Otolaryngology (182)
- Pain Medicine (126)
- Palliative Medicine (44)
- Pathology (265)
- Pediatrics (580)
- Primary Care Research (234)
- Public and Global Health (4123)
- Radiology and Imaging (676)
- Respiratory Medicine (549)
- Rheumatology (225)
- Sports Medicine (177)
- Surgery (207)
- Toxicology (39)
- Transplantation (109)
- Urology (81)